Menu
GeneBe

rs111768745

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001160372.4(TRAPPC9):c.3149G>A(p.Arg1050Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,606,834 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1050W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00098 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0020 ( 7 hom. )

Consequence

TRAPPC9
NM_001160372.4 missense

Scores

2
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2O:1

Conservation

PhyloP100: 2.54
Variant links:
Genes affected
TRAPPC9 (HGNC:30832): (trafficking protein particle complex subunit 9) This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01266858).
BP6
Variant 8-139732109-C-T is Benign according to our data. Variant chr8-139732109-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 362064.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=5, not_provided=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000978 (149/152320) while in subpopulation NFE AF= 0.00184 (125/68026). AF 95% confidence interval is 0.00158. There are 2 homozygotes in gnomad4. There are 72 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TRAPPC9NM_001160372.4 linkuse as main transcriptc.3149G>A p.Arg1050Gln missense_variant 22/23 ENST00000438773.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TRAPPC9ENST00000438773.4 linkuse as main transcriptc.3149G>A p.Arg1050Gln missense_variant 22/231 NM_001160372.4 P1Q96Q05-1

Frequencies

GnomAD3 genomes
AF:
0.000979
AC:
149
AN:
152202
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00184
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000860
AC:
201
AN:
233732
Hom.:
0
AF XY:
0.000859
AC XY:
109
AN XY:
126950
show subpopulations
Gnomad AFR exome
AF:
0.000207
Gnomad AMR exome
AF:
0.0000901
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000519
Gnomad NFE exome
AF:
0.00184
Gnomad OTH exome
AF:
0.000175
GnomAD4 exome
AF:
0.00197
AC:
2859
AN:
1454514
Hom.:
7
Cov.:
32
AF XY:
0.00185
AC XY:
1335
AN XY:
722930
show subpopulations
Gnomad4 AFR exome
AF:
0.000150
Gnomad4 AMR exome
AF:
0.0000682
Gnomad4 ASJ exome
AF:
0.0000386
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000115
Gnomad4 NFE exome
AF:
0.00252
Gnomad4 OTH exome
AF:
0.000866
GnomAD4 genome
AF:
0.000978
AC:
149
AN:
152320
Hom.:
2
Cov.:
33
AF XY:
0.000967
AC XY:
72
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00184
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.00155
Hom.:
0
Bravo
AF:
0.00103
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000819
AC:
99
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Intellectual disability Uncertain:2
Uncertain significance, no assertion criteria providedclinical testingCentre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de LilleJan 01, 2019- -
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterMay 24, 2019- -
Intellectual disability, autosomal recessive 13 Uncertain:1Other:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJul 13, 2018This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2021- -
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 21, 2024- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 13, 2015- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 09, 2018The p.R1148Q variant (also known as c.3443G>A), located in coding exon 22 of the TRAPPC9 gene, results from a G to A substitution at nucleotide position 3443. The arginine at codon 1148 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Intellectual Disability, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.47
Cadd
Benign
22
Dann
Uncertain
1.0
DEOGEN2
Benign
0.012
T;T;.;T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.14
FATHMM_MKL
Uncertain
0.84
D
M_CAP
Benign
0.0086
T
MetaRNN
Benign
0.013
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.55
N;N;.;N
MutationTaster
Benign
0.93
N;N;N
PrimateAI
Benign
0.29
T
Polyphen
0.88
P;P;B;P
Vest4
0.37, 0.37
MVP
0.13
MPC
0.081
ClinPred
0.022
T
GERP RS
3.4
Varity_R
0.034
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs111768745; hg19: chr8-140744352; COSMIC: COSV99068074; COSMIC: COSV99068074; API